Pulmonary Involvement in Sjögren’s Syndrome: Correlations with Biomarkers of Activity and High-Resolution Computer Tomography Findings
(1) Background: Sjögren’s syndrome (SS) represents a systemic autoimmune disease whose pathophysiology has yet to be elucidated, though it is known that the inflammatory process encountered in SS is of a systemic nature, with cytokines representing the main mediators for tissue damage. (2) Aim of th...
Main Authors: | Deiana Roman, Stela Iurciuc, Alexandru Caraba |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/4/1100 |
Similar Items
-
Altered subgroups of regulatory T cells in patients with primary Sjögren's syndrome
by: Jing-Chi Lin, et al.
Published: (2023-05-01) -
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry
by: Alexandre Dumusc, et al.
Published: (2018-02-01) -
Inhalative Treatment of Laryngitis Sicca in Patients with Sjögren’s Syndrome—A Pilot Study
by: Benedikt Hofauer, et al.
Published: (2022-02-01) -
A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren’s syndrome patients
by: Wei Bai, et al.
Published: (2023-02-01) -
Abnormal expression of CXCL13, MIF
and IL-35 in patients with primary Sjögren’s syndrome and its relationship with disease severity
by: Ronghua Wang, et al.
Published: (2023-05-01)